Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry
European Journal of Internal Medicine · 2026-03 · 145 · 106512
DOI: 10.1016/j.ejim.2025.106512 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Internal Medicine, 2026-03. Verfasst von Davide Antonio Mei und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, …. Hauptthemen laut MEDLINE: Atrial Fibrillation, Fibrinolytic Agents, Cardiovascular Diseases, Kidney Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Cardiovascular, kidney, and metabolic (CKM) conditions frequently coexist with atrial fibrillation (AF), but their impact in AF population remains poorly characterized. OBJECTIVE: To evaluate the prevalence, clinical impact of CKM domains and the effect of integrated care on outcomes in a European cohort of patients with AF. METHODS: In the EORP-AF General Long-Term Registry, we define CKM domains according to cardiovascular, kidney and metabolic conditions. Patients were stratified by the number and combinations of CKM domains. The primary outcome was a composite of all-cause death, acute coronary syndrome, and thromboembolic events. The impact of adherence to the Atrial fibrillation Better Care (ABC) integrated care pathway was assessed. RESULTS: Among 7,736 individuals included in the analysis (39.8 % women; mean age 68.1 [SD 11.6] years), CKM domains were highly prevalent (93.7 % had ≥1 domain; 21.4 % had all three), with regional variation. A higher burden of CKM domains was associated with increased risk of primary outcome events (hazard ratio [HR] [95 % confidence interval] 1 vs 0 domains: HR 1.45 [0.93-2.26]; 2 vs 0: HR 2.05 [1.32-3.19]; 3 vs 0: HR 2.69 [1.71-4.23]). Groups including the cardiovascular domain, especially cardio-kidney, had the highest hazard of events (HR 4.00 [2.41-6.65]). ABC pathway adherence was associated with lower risk of events consistently across number (Pint = 0. 585) and group (Pint = 0.063) of CKM domains. CONCLUSIONS: In this large cohort of European AF patients, CKM domains were highly prevalent and associated with progressively worse outcomes. ABC-integrated care was associated with favourable outcomes across CKM profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy; Clinical and Experimental Medicine PhD Program, University of M…
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy; Liverpool Centre for Cardiovascular Science at University of Li…
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK; Department of Translational and Precision Medicine, Sapienza…
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
- Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, IMIB-Arrixaca, University of Murcia, CIBERCV, Murcia, Spain.
- Department of Medical and Surgical Sciences, Institute of Cardiology, University of Bologna, Policlinico S.Orsola-Malpighi, via Massarenti 9, Bologna, 40138, Italy; Dipartimento Cardio-toraco-vascolare, UOC di Cardiolog…
Zitieren
APA
Mei, D. A., Imberti, J. F., Vitolo, M., Romiti, G. F., Corica, B., Mantovani, M., Bonini, N., Cherubini, B., Marin, F., Diemberger, I., Dan, G. A., Potpara, T., Proietti, M., Lip, G. Y. H., & Boriani, G. (2026). Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry. European Journal of Internal Medicine, 145, 106512. https://doi.org/10.1016/j.ejim.2025.106512
Vancouver
Mei DA, Imberti JF, Vitolo M, Romiti GF, Corica B, Mantovani M, et al. Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry. European Journal of Internal Medicine. 2026;145:106512. doi:10.1016/j.ejim.2025.106512
BibTeX
@article{Mei2026,
author = {Mei, Davide Antonio and Imberti, Jacopo Francesco and Vitolo, Marco and Romiti, Giulio Francesco and Corica, Bernadette and Mantovani, Marta and Bonini, Niccolò and Cherubini, Benedetta and Marin, Francisco and Diemberger, Igor and Dan, Gheorghe Andrei and Potpara, Tatjana and Proietti, Marco and Lip, Gregory Y H and Boriani, Giuseppe},
title = {Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry},
journal = {European Journal of Internal Medicine},
year = {2026},
volume = {145},
pages = {106512},
doi = {10.1016/j.ejim.2025.106512}
}
EUVIMED